Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease .
NCT04105439 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2021-01-13
Summary
The purpose of the study is to determine whether plasma levels of the soluble urokinase plasminogen activator(suPAR) can serve as a blood-based biomarker for diagnosis of Behçet's disease and its correlation with disease activity.
Conditions
- Behçet Disease
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-01
- Primary Completion
- 2021-11-01
- Completion
- 2021-12-01
More Related Trials
-
Thrombophilia and Thrombosis in Behçet's Disease
NCT06451575 ·Status: RECRUITING
-
Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls
NCT07276087 ·Status: RECRUITING
-
Withdrawal of Colchicine in Behçet Syndrome
NCT06146192 ·Status: NOT_YET_RECRUITING
-
Clinical, Laboratory, and Therapeutic Analysis of Behçet's Disease in Assiut
NCT07157189 ·Status: NOT_YET_RECRUITING
-
A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease
NCT02307513 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Regulatory B Cells in Behçet's Disease
NCT04376411 ·Status: COMPLETED
-
Eosinophil and Anticoagulation in COVID-19 Patients
NCT04507282 ·Status: COMPLETED
-
Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis
NCT01539902 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
NCT05767047 ·Status: RECRUITING ·Phase: PHASE3
-
Ustekinumab in BEhçet's Syndrome STudy
NCT07244614 ·Status: RECRUITING
-
Detection of Subclinical Enthesitis by Ultrasonography
NCT04209894 ·Status: COMPLETED
-
Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease
NCT06721234 ·Status: RECRUITING
-
The Serum Angiotensin Converting Enzyme and Lysozyme Levels in Patients Non-infectious and Infectious Uveitis
NCT02627209 ·Status: UNKNOWN ·Phase: NA
-
Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
NCT04528082 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)
NCT04882072 ·Status: TERMINATED ·Phase: PHASE3
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2
-
Behçet's Disease and Eosinophil Cationic Protein
NCT01584778 ·Status: COMPLETED
-
MEVALONATE KINASE GENE MUTATIONS AND THEIR CLINICAL CORRELATIONS IN BEHÇET'S DISEASE
NCT01780363 ·Status: COMPLETED
-
Annexin A1 Levels in SARS-CoV-2 Infection
NCT04948229 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis
NCT03725202 ·Status: COMPLETED ·Phase: PHASE3
-
Plasmapheresis Before Rituximab in Cryoglobulinemia
NCT04692363 ·Status: UNKNOWN
-
1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement
NCT02756650 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy
NCT05894512 ·Status: COMPLETED
-
Plasma Adiponectin Levels and Relations With Cytokines in Children With Acute Rheumatic Fever
NCT01886846 ·Status: COMPLETED
-
Cytokines in Blister Fluids of Bullous Pemphigoid (BP)
NCT03856840 ·Status: COMPLETED